Abstract
Mesenchymal stromal (stem) cells have potential in regenerative medicine and modulating the immune system. To deliver any cell-based therapy to the patient, it must be cryopreserved, most commonly in DMSO, which impacts cell function and causes clinical side effects. Here we report the use of a synthetically scalable polyampholyte to rescue the cryopreservation of mesenchymal stromal cells in low [DMSO] cryopreservation. Flow cytometry showed retention of key markers of multipotency comparable to 10% (v/v) DMSO, and the cells could be differentiated, showing this polymer material can be used to improve, or replace, current cryopreservation strategies.
Original language | English |
---|---|
Pages (from-to) | 5627–5632 |
Number of pages | 6 |
Journal | ACS Applied Bio Materials |
Volume | 3 |
Issue number | 9 |
Early online date | 18 Aug 2020 |
DOIs | |
Publication status | Published - 21 Sept 2020 |
Keywords
- cryopreservation
- stem cells
- polymers
- polyampholyte
- biomaterials